Literature DB >> 30694572

Prognostic significance of fatty acid binding protein-4 in the invasive ductal carcinoma of the breast.

Yinji Cui1,2, Meiying Song1, Su Young Kim1,2.   

Abstract

We conducted this study to identify clinico-pathologic and prognostic factors that are associated with fatty acid binding protein-4 (FABP4) and to discuss its therapeutic potentials in patients with breast cancer (BC). In a total of 75 patients with an established diagnosis of invasive ductal carcinoma of the breast, we performed a retrospective analysis of the medical records and analyzed their immunohistochemical findings. Following evaluation of baseline and clinico-pathological characteristics such as the age, immunohistochemical expressions of FABP4, TNM stage, tumor grade, lymphatic and perineural invasion, estrogen receptor (ER) and progesterone receptor (PR), disease-free survival (DFS), overall survival (OS), recurrence and death, we analyzed correlations of the expression of FABP4 with clinico-pathologic and prognostic factors. Our results showed that tumor grade and recurrence had a significant correlation with the expression of FABP4 (P = 0.002 and 0.049, respectively). Moreover, we also found that the DFS had a significant correlation with the expression of FABP4 (P = 0.049). It can therefore be concluded that the expression of FABP4 might have a prognostic value in patients with BC. But further studies are warranted to establish its potentials as a prognostic indicator.
© 2019 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  breast cancer; disease-free survival; invasive ductal carcinoma; prognostic indicator

Mesh:

Substances:

Year:  2019        PMID: 30694572     DOI: 10.1111/pin.12756

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

1.  Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2.

Authors:  Keith Wirth; Shuhei Shinoda; Mizuho Sato-Dahlman; Deborah M Dickey; David A Bernlohr; Sayeed Ikramuddin; Masato Yamamoto
Journal:  Surg Obes Relat Dis       Date:  2021-12-08       Impact factor: 4.734

2.  Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.

Authors:  Dabin Wu; Ling Xiang; Linglong Peng; Haitao Gu; Yunhao Tang; Haoyun Luo; Hang Liu; Yaxu Wang
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.

Authors:  Ya Guo; Zhong Wei Wang; Wang Hui Su; Jing Chen; Ya Li Wang
Journal:  Biomed Res Int       Date:  2020-06-27       Impact factor: 3.411

Review 4.  Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer.

Authors:  Naihui Sun; Xing Zhao
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

5.  Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.

Authors:  Adam Hermawan; Herwandhani Putri
Journal:  BMC Genom Data       Date:  2022-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.